The eosinophil ribonucleases

Cellular and Molecular Life Sciences

Volumn 54, Issue 8, 1998, Pages 795-803

  Rosenberg, H F ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Eosinophils; Evolution; Host defence; Primates; Rodents

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; NEUROTOXIN; RIBONUCLEASE; RIBONUCLEASE A;

EOSINOPHIL; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; EOSINOPHILS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RIBONUCLEASES; SEQUENCE HOMOLOGY, AMINO ACID;

PRIMATES; RODENTIA;

EID: 0031717373     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050208     Document Type: Review

References (95)

1. Ehrlich P. (1897) On the specific granulations of blood [translation]. Arch. Anat. Physiol. 166
2. Ehrlich P. (1880) Methodological contribution on the physiology and pathology of various forms of leukocytes [translation]. Z. Klin. Med. 1: 553
3. Spry C. J. F. (1988) Eosinophils: A Comprehensive Guide to the Scientific and Medical Literature, Oxford University Press, Oxford
4. Weller P. F. (1994) Eosinophils: structure and functions. Curr. Opin. Immunol. 6: 85-90
5. Weller P. F. (1991) The immunobiology of eosinophils. N. Engl. J. Med. 324: 1110-1118
6. Gleich G. J. (1992) Eosinophils. In: Inflammation, chap. 22, pp. 663-700, Gallin J. I., Goldstein I. M. and Snyderman R. (eds), Raven Press, New York
7. Kay A. B. (1990) Eosinophils, Allergy and Asthma, Blackwell Scientific Publications, Oxford
8. Weller P. F. and Bubley G. J. (1994) The idiopathic hypereosinophilic syndrome. Blood 83: 2759-2779
9. Hirsch J. G. and Hirsch B. I. (1980) Paul Ehrlich and the discovery of the eosinophil. In: The Eosinophil in Health and Disease, pp. 3-24, Mahmoud A. A. F. and Austen K. F. (eds), Grune and Stratton, New York
10. Archer G. T. and Hirsch J. G. (1963) Isolation of granules from eosinophil leucocytes and study of their enzyme content. J. Exp. Med. 118: 277-284
11. Olsson I. and Venge P. (1972) Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells. Scand. J. Haematol. 9: 204-214
12. Olsson I. and Venge P. (1974) Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood 44: 235-246
13. Olsson I., Venge P., Spitznagel J. K. and Lehrer R. I. (1977) Arginine-rich cationic proteins of human eosinophil granules. Comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab. Invest. 36: 493-500
14. Olsson I., Persson A. M. and Winqvist I. (1986) Biochemical properties of eosinophil cationic protein and demonstration of its biosynthesis in vitro in marrow cells from patients with eosinophilia. Blood 67: 498-503
15. Durack D. T., Sumi S. M. and Klebanoff S. J. (1979) Neurotoxicity of human eosinophils. Proc. Natl. Acad. Sci. USA 76: 1443-1447
16. Durack D. T., Ackerman S. J., Loegering D. A. and Gleich G. J. (1981) Purification of human eosinophil-derived neurotoxin. Proc. Natl. Acad. Sci., USA 78: 5165-5169
17. Gordon M. H. (1933) Remarks on Hodgkin's disease: a pathologic agent in the glands and its application in diagnosis. Br. Med. J. 1: 641-647
18. Peterson C. G. B. and Venge P. (1983) Purification and characterization of a new cationic protein eosinophil protein-X (EPX) from granules of human eosinophils. Immunology 50: 19-26
19. Slifman N. R., Venge P., Peterson C. G. B., McKean D. J. and Gleich G. J. (1989) Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein. J. Immunol. 143: 2317-2322
20. Venge P., Dahl R. and Hallgren R. (1979) Enhancement of F XII-dependent reactions by eosinophil cationic protein. Thromb. Res. 14: 641-649
21. Dahl R. and Venge P. (1979) Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes. Thromb. Res. 14: 599-608
22. Weiler J. M., Edens R. E., Bell C. S. and Gleich G. J. (1995) Eosinophil granule cationic proteins regulated the classical pathway of complement. Immunology 84: 213-219
23. Ackerman S. J., Gleich G. J., Loegering D. A., Richardson B. A. and Butterworth A. E. (1985) Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 34: 735-745
24. Hamann K. J., Gleich G. J., Checkel J. L., Loegering D. A., McCall J. W. and Barker R. L. (1990) In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. J. Immunol. 144: 3166-3173
25. Hamann K. J., Barker R. L., Loegering D. A. and Gleich G. J. (1987) Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. J. Parasitol. 73: 523-529
26. Molina H. A., Kierszenbaum F., Hamann K. J. and Gleich G. J. (1988) Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 38: 327-334
27. McClaren D. J., McKean J. R., Olsson I., Venge P. and Kay A. B. (1981) Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol. 3: 359-373
28. Yazdanbakhsh M., Tai P. C., Spry C. J., Gleich C. J. and Roos D. (1987) Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni. J. Immunol. 138: 3443-3447
29. Waters L. S., Taverne J., Tai P. C., Spry C. J., Targett G. A. and Playfair J. H. (1987) Killing of Plasmodium falciparum by eosinophil secretory products. Infect. Immun. 55: 877-881
30. Lehrer R. I., Szklarek D., Barton A., Ganz T., Hamann K. J. and Gleich G. J. (1989) Antibacterial properties of eosinophil major basic protein and esoinophil cationic protein. J. Immunol. 142: 4428-4434
31. Motojima S., Frigas E., Loegering D. A. and Gleich G. J. (1989) Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am. Rev. Respir. Dis. 139: 801-805
32. Tai P. C., Ackerman S. J., Spry C. J., Dunnette S., Olsen E. G. and Gleich G. J. (1987) Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1: 643-647
33. Venge P., Dahl R., Fredens K. and Peterson C. G. B. (1988) Epithelial injury by human eosinophils. Am. Rev. Respir. Dis. 138: S54-S57
34. Young J. D. E., Peterson C. G. B., Venge P. and Cohn Z. A. (1986) Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321: 613-616
35. Fredens K., Dybdahl H., Dahl R. and Baandrup U. (1988) Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage. APMIS 96: 711-719
36. Gleich G. J., Loegering D. A., Bell M. P., Checkel J. L., Ackerman S. J. and McKean D. J. (1986) Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc. Natl. Acad. Sci. USA 83: 3146-3150
37. Slifman N. R., Loegering D. A., McKean D. J. and Gleich G. J. (1986) Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J. Immunol. 137: 2913-2917
38. Gullberg U., Widegren B., Arivason U., Egesten A. and Olsson I. (1986) The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity. Biochem. Biophys. Res. Commun. 139: 1239-1242
39. Rosenberg H. F. and Dyer K. D. (1997) Diversity among the primate eosinophil-derived neurotoxin genes: a specific carboxy-terminal sequence is necessary for enhanced ribonuclease activity. Nucleic Acids Res. 25: 3532-3536
40. Libonati M. and Sorrentino S. (1992) Revisiting the action of bovine ribonuclease A and pancreatic-type ribonucleases on double-stranded RNA. Mol. Cell. Biochem. 117: 139-151
41. Sorrentino S. and Libonati M. (1994) Human pancreatic-type and non-pancreatic-type ribonucleases: a direct side-by-side comparison of their catalytic properties. Arch. Biochem. Biophys. 312: 340-348
42. Libonati M., Bertoldi M. and Sorrentino S. (1996) The activity on double-stranded RNA of aggregates of ribonuclease A higher than dimers increases as a function of the size of the aggregates. Biochem. J. 318: 287-290
43. Yakovlev G. I., Sorrentino S., Moiseyev G. P. and Libonati M. (1995) Double-stranded RNA: the variables controlling its degradation by RNases. Nucleic Acids Symp. Ser. 33: 106-108
44. Rosenberg H. F., Jenen D. G. and Ackerman S. J. (1989) Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc. Natl. Acad. Sci. USA 86: 4460-4464
45. Hamann K. J., Barker R. L, Loegering D. A., Pease L. R. and Gleich G. J. (1989) Sequence of human cosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human nonsecretory ribonucleases. Gene 83: 161-167
46. Rosenberg H. F., Ackerman S. J. and Tenen D. G. (1989) Human eosinophil cationic protein: molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J. Exp. Med. 170: 163-176
47. Barker R. L., Loegering D. A., Ten R. M., Hamann K. J., Pease L. R. and Gleich G. J. (1989) Eosinophil cationic protein cDNA: comparison with other toxic cationic proteins and ribonucleases. J. Immunol. 143: 952-955
48. Weickmann J. L., Elson M. and Glitz D. G. (1981) Purification and characterization of human pancreatic ribonuclease. Biochemistry 20: 1272-1278
49. Haugg M. and Schein C. H. (1992) The DNA sequences of human and hamster secretory ribonucleases determined with the polymerase chain reaction. Nucleic Acids Res. 20: 612
50. Blackburn P. and Moore S. (1982) Pancreatic ribonucleases. In: The Enzymes, Boyer P. (ed.), Academic Press, New York
51. Morita T., Niwata Y., Ohgi K., Ogawa M. and Irie M. (1985) Distribution of two urinary ribonuclease-like enzymes in human organs and body fluids. J. Biochem. 99: 17-25
52. Beintema J. J., Hofsteenge J., Iwama M., Morita T., Ohgi K., Irie M. et al. (1988) Amino acid sequence of the non-secretory ribonuclease of human urine. Biochemistry 27: 4530-4538
53. Sorrentino S., Tucker G. K. and Glitz D. G. (1988) Purification and characterization of a ribonuclease from human liver. J. Biol. Chem. 263: 16125-16131
54. Tiffany H. L., Li F. and Rosenberg H. F. (1995) Hyperglycosylation of eosinophil ribonucleases in a promyelocytic leukemia cell line and in differentiated peripheral blood progenitor cells. J. Leukoc. Biol. 58: 49-54
55. Futami J., Tsushima Y., Murato Y., Tada H., Sasaki J., Seno M. et al. (1997) Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans. DNA Cell Biology 16: 413-419
56. Paul C. C., Ackerman S. J., Mahrer S., Tolbert M., Dvorak A. M. and Baumann M. A. (1994) Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line. AML14. J. Leukoc. Biol. 56: 74-79
57. Tiffany H. L., Handen J. S. and Rosenberg H. F. (1996) Enhanced expression of the eosinophil-derived neurotoxin ribonuclease (RNS2) gene requires interaction between the promoter and intron. J. Biol. Chem. 271: 12387-12393
58. Hamann K. J., Ten R. M., Loegering D. A., Jenkins R. B., Heise M. T., Schad C. R. et al. (1990) Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. Genomics 7: 535-546
59. Kurachi K., Davie E. W., Strydom D. J., Riordan J. F. and Vallee B. F. (1985) Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry 24: 5494-5499
60. Rosenberg H. F. and Dyer K. D. (1995) Human ribonuclease 4 (RNase 4): coding sequence, chromosomal localization and identification of two distinct transcripts in human somatic tissues. Nucleic Acids Res. 23: 4290-4295
61. Rosenberg H. F. and Dyer K. D. (1996) Molecular cloning and characterization of a novel human ribonuclease (RNase k6): increasing diversity in the enlarging ribonuclease gene family. Nucleic Acids Res. 24: 3507-3513
62. Mastrianni D. M., Eddy R. L., Rosenberg H. F., Corrette S. E., Shows T. B., Tenen D. G. et al. (1992) Localization of the human eosinophil Charcot-Leyden crystal protein (lysophospholipase) gene (CLC) to chromosome 19 and the human ribonuclease 2 (eosinophil-derived neurotoxin) and ribonuclease 3 (eosinophil cationic protein) genes (RNS2 and RNS3) to chromosome 14. Genomics 13: 240-242
63. Mosimann S. C., Newton D. L., Youle R. J. and James M. N. G. (1996) X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 angstroms resolution. J. Mol. Biol. 260: 540-552
64. Newton D. L., Walbridge S., Mikulski S. M., Ardelt W., Shogen K., Ackerman S. J. et al. (1994) Toxicity of an anti-tumor ribonuclease to Purkinje neurons. J. Neurosci. 14: 538-544
65. Sorrentino S., Glitz D. G., Hamann K. J., Loegering D. A., Checkel J. L. and Gleich G. J. (1992) Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activily. J. Biol. Chem. 267: 14589-14565
66. Rosenberg H. F. (1995) Recombinant eosinophil cationic protein (ECP): ribonuclease activity is not essential for cytotoxicity. J. Biol. Chem. 270: 7876-7881
67. Murphy P. M. (1993) Molecular mimicry and the generation of host defense protein diversity. Cell 72: 823-826
68. Spry C. J. F. (1988) Eosinophils in animals other than man. In: Eosinophils: A Comprehensive Review and Guide to the Scientific and Medical Literature, chap. 7, pp. 123-127, Oxford University Press, Oxford
69. Rosenberg H. F., Dyer K. D., Tiffany H. L. and Gonzalez M. (1995) Rapid evolution of a unique family of primate ribonuclease genes. Nature Genet. 10: 219-223
70. Rosenberg H. F. and Dyer K. D. (1995) Eosinophil cationic protein and eosinophil-derived neurotoxin: evolution of novel function in a primate ribonuclease gene family. J. Biol. Chem. 270: 21539-21544
71. Beintema J. J. (1989) Presence of a basic amino acid residue at either position 66 or 122 is a condition for enzymic activity in the ribonuclease superfamily. FEBS Lett. 254: 1-4
72. Russo N., Nobile V., Di Donato A., Riordan J. F. and Vallee B. L. (1996) The C-terminal region of human angiogenin has a dual role in enzymatic activity. Proc. Natl. Acad. Sci. USA 93: 3243-3247
73. Niwata Y., Ohgi K., Sanda A., Takizawa A. and Irie M. (1985) Purification and properties of bovine kidney ribonucleases. J. Biochem. 97: 923-934
74. Irie M., Nitta R., Ohgi K., Niwata Y., Watanabe H., Iwama M. et al. (1988) Primary structure of a non-secretory ribonuclease from bovine kidney. J. Biochem. 104: 289-296
75. Iwama M., Sanda A., Ohgi K., Hofsteenge J. and Irie M. (1993) Purification and primary structure of a porcine kidney non-secretory ribonuclease. Biosci. Biotechnol. Biochem. 57: 2133-2138
76. Deming M. S., Dyer K. D., Bankier A. T., Piper M. B., Dear P. H. and Rosenberg H. F. (1998) Ribonuclease k6: chromosomal mapping and divergent rates of evolution in the RNase A superfamily. Genome Res. 8: 599-607
77. Larson K. A., Olson E. A., Madden B. J., Gleich G. J., Lee N. A. and Lee J. J. (1996) Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. Proc. Natl. Acad. Sci. USA 93: 12370-12375
78. Watanabe M., Nittoh T., Suzuki T., Kitoh A., Mue S. and Ohuchi K. (1995) Isolation and partial characterization of eosinophil granule proteins in rats: eosinophil cationic protein and major basic protein. Int. Arch. Allergy Immunol. 108: 11-18
79. Nittoh T., Hirakata M., Mue S. and Ohuchi K. (1997) Identification of cDNA encoding rat eosinophil cationic protein eosinophil-associated ribonuclease. Biochim. Biophys. Acta 1351: 42-46
80. Batten D., Dyer K. D., Domachowske J. B. and Rosenberg H. F. (1997) Molecular cloning of four novel murine ribonuclease genes: unusual expansion within the Ribonuclease A gene family. Nucleic Acids Res. 25: 4235-4239
81. Garofalo R., Kimpen J. L. L., Welliver R. C. and Ogra P. L. (1992) Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120: 28-32
82. Kimpen J. L., Garofalo R., Welliver R. C. and Ogra P. L. (1992) Activation of human eosinophils by respiratory syncytial virus. Pediatric Res. 32: 160-164
83. Kimpen J. L., Garofalo R., Welliver R. C., Fujihara K. and Ogra P. L. (1996) An ultrastructural study of the interaction of human eosinophils with respiratory syncytial virus. Pediatr. Allergy Immunol. 7: 48-53
84. Domachowske J. B., Dyer K. D., Bonville C. A. and Rosenberg H. F. (1998) Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J. Infect. Dis. 177: 1458-1464
85. Klebanoff S. J. and Coombs R. W. (1996) Virucidal effect of stimulated eosinophils on human immunodeficiency virus type I. AIDS Res. Hum. Retroviruses 12: 25-29
86. Domachowske J. B. and Rosenberg H. F. (1997) Eosinophils inhibit retroviral transduction of human target cells by a ribonudease-dependent mechanism. J. Leukoc. Biol. 62: 363-368
87. Cohen A. J. and Steigbigel R. T. (1996) Eosinophilia in patients infected with human-immunodeficiency-virus. J. Infect. Dis. 174: 615-618
88. Skiest D. J. and Keiser P. (1997) Clinical significance of eosinophilia in HIV-infected individuals. Am. J. Med. 102: 449-453
89. Newton D. L., Nicholls P. J., Rybak S. M. and Youle R. J. (1994) Expression and characterization of recombinant human eosinophil-derived neurotoxin and esoinophil-derived neurotoxin-anti-transferrin receptor sFv. J. Biol. Chem. 269: 26739-26745
90. Newton D. L., Xue Y., Boque L., Wlodawer A., Kung H. F. and Rybak S. M. (1997) Expression and characterization of a cytotoxic human-frog chimeric ribonuclease potential for cancer therapy. Protein Eng. 10: 463-470
91. Kardana A., Bagshawe K. D., Coles B., Read D. and Taylor M. (1993) Characterisation of UGP and its relationship with beta-core fragment. Br. J. Cancer 67: 686-692
92. Griffiths S. J., Adams D. J. and Talbot S. J. (1997) Ribonuclease inhibits Kaposi's sarcoma. Nature 390: 568
93. Handen J. S. and Rosenberg H. F. (1997) Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence. J. Biol. Chem. 272: 1665-1669
94. Carsana A., Confalone E., Palmieri M., Libonati M. and Furia A. (1988) Structure of the bovine pancreatic ribonuclease gene: the unique intervening sequence in the 5′ untranslated region contains a promoter-like element. Nucleic Acids Res. 16: 5491-5502
95. Schuller C., Nijssen H. M., Kok R. and Beintema J. J. (1990) Evolution of nucleic acids coding for ribonucleases: the mRNA sequence of mouse pancreatic ribonuclease. Mol. Biol. Evol. 7: 29-44